INCR — Intercure Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1857030 ·
Last close
$3.61
Market Cap
$54.16M
52W High
$7.55
52W Low
$3.12
ADV30
9,847
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Dec 2025 — — — — 690,552,000 46,466,000 294,195,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-314,615,000
Inventory
$108,064,000
Receivables
$154,470,000
ST Investments
$209,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 270,200,000 6,733,000 -35,710,000 690,552,000 294,195,000 396,521,000 16,841,000
Dec 2024 238,845,000 -45,056,000 -67,795,000 762,574,000 364,903,000 396,969,000 -66,926,000
Dec 2023 355,553,000 37,593,000 -61,959,000 786,614,000 329,552,000 455,112,000 -53,631,000
Dec 2022 388,684,000 41,200,000 44,819,000 958,007,000 436,530,000 501,305,000 51,267,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.48

Peers — same industry

TickerNameMarket CapLastDaily %
XBIT XBiotech Inc. $54.27M $1.78 —
VRCA Verrica Pharmaceuticals Inc. $53.94M $3.14 —
QUCY Quantum Cyber N.V. $54.38M $0.62 —
HRTX HERON THERAPEUTICS, INC. /DE/ $53.70M $0.28 —
IBO IMPACT BIOMEDICAL INC. $53.31M $6.17 —

News headlines (Yahoo Finance, 1h cache)

InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-09-08 20:12 · Yahoo
InterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive?
2026-08-27 20:22 · Yahoo
InterCure Ltd. Announces 1-for-5 Reverse Share Split
2026-08-19 13:00 · Yahoo
InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages
2026-08-24 11:00 · Yahoo
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
2026-06-22 12:50 · Yahoo
InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
2026-06-15 13:25 · Yahoo
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
2026-04-30 22:05 · Yahoo
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
2026-02-19 12:00 · Yahoo
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
2026-02-19 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.